Article
In-silico analysis reveals druggable single nucleotide polymorphisms in angiotensin 1 converting enzyme involved in the onset of blood pressure.
BMC research notes - 20 Dec 2021
Udosen Brenda, Soremekun Opeyemi, Ekenna Chinwe, Idowu Omotuyi Olaposi, Chikowore Tinashe, Nashiru Oyekanmi, Fatumo Segun
Abstract excerpt
OBJECTIVE: The Angiotensin 1 converting enzyme (ACE1) gene plays a critical role in regulating blood pressure and thus, it has become a major therapeutic target of antihypertensives. Single nucleotide polymorphisms (SNPs) occurring within a gene most especially at the functional segment of the genes alter the structure-function relationship of that gene. RESULTS: Our study revealed that five nsSNPs of the ACE1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
